Skip to main content

1-2 of 2 results for subject:Pfizer

Subject X
Marketing

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Marketing (2)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)

I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the Government has agreed to relating to the two contracts signed between Her Majesty’s Government (HMG) and...

Member
Sajid Javid (Conservative)
Department
Department of Health and Social Care
Type
Written statements
Date
19 January 2022
Reference
HCWS545
House
House of Commons

My Rt Hon Friend the Secretary of State for Health and Social Care (Sajid Javid) has made the following written statement:

Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)

I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention...

Member
Lord Kamall (Conservative)
Department
Department of Health and Social Care
Type
Written statements
Date
19 January 2022
Reference
HLWS532
House
House of Lords